Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Papa John's
PZZA
$806M
| $16.4M | ﹤0.01% |
399,784
+15,892
| +4% | +$679K |
|
|
ECG
1727
Everus Construction Group
ECG
$6.99B
| $16.4M | ﹤0.01% |
442,074
+30,961
| +8% | +$1.67M |
|
1728
Levi Strauss
LEVI
$9.39B
| $16.4M | ﹤0.01% |
1,051,720
+104,722
| +11% | +$1.82M |
|
1729
Alkami Technology
ALKT
$2.11B
| $16.4M | ﹤0.01% |
624,107
+24,906
| +4% | +$784K |
|
1730
Uranium Energy
UEC
$5.57B
| $16.4M | ﹤0.01% |
3,420,671
+11,542
| +0.3% | +$72.4K |
|
1731
Donnelley Financial Solutions
DFIN
$1.16B
| $16.3M | ﹤0.01% |
373,927
+320
| +0.1% | +$17.7K |
|
1732
CTS Corp
CTS
$1.89B
| $16.3M | ﹤0.01% |
393,323
+633
| +0.2% | +$29.6K |
|
|
CALY
1733
Callaway Golf Company
CALY
$3.14B
| $16.3M | ﹤0.01% |
2,478,250
+191,531
| +8% | +$1.41M |
|
1734
Dillards
DDS
$9.56B
| $16.3M | ﹤0.01% |
45,581
-3,001
| -6% | -$1.29M |
|
1735
Lucid Motors
LCID
$2.77B
| $16.3M | ﹤0.01% |
674,040
+14,470
| +2% | +$387K |
|
1736
Pediatrix Medical
MD
$2.2B
| $16.3M | ﹤0.01% |
1,124,952
-33,288
| -3% | -$473K |
|
1737
Ambarella
AMBA
$3.81B
| $16.3M | ﹤0.01% |
323,500
-1,501
| -0.5% | -$103K |
|
1738
Clarivate
CLVT
$1.16B
| $16.2M | ﹤0.01% |
4,129,983
-164,935
| -4% | -$781K |
|
1739
Powell Industries
POWL
$7.71B
| $16.1M | ﹤0.01% |
284,400
+954
| +0.3% | +$66.5K |
|
|
AIV
1740
Aimco
AIV
$383M
| $16.1M | ﹤0.01% |
1,833,711
-17,855
| -1% | -$159K |
|
1741
Kohl's
KSS
$2.19B
| $16.1M | ﹤0.01% |
1,968,634
+197,088
| +11% | +$2.29M |
|
|
PTVE
1742
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $16.1M | ﹤0.01% |
894,104
-97,899
| -10% | -$1.74M |
|
|
AGNT
1743
AGNT Inc
AGNT
$734M
| $16M | ﹤0.01% |
1,639,766
+228,103
| +16% | +$2.42M |
|
1744
Kinetik
KNTK
$3.62B
| $16M | ﹤0.01% |
308,368
-5,142
| -2% | -$301K |
|
1745
Argan
AGX
$8.37B
| $16M | ﹤0.01% |
121,919
-21,716
| -15% | -$3.03M |
|
1746
ANI Pharmaceuticals
ANIP
$1.78B
| $16M | ﹤0.01% |
238,377
+2,220
| +0.9% | +$133K |
|
|
FBRT
1747
Franklin BSP Realty Trust
FBRT
$657M
| $15.9M | ﹤0.01% |
1,244,760
+81,783
| +7% | +$1.06M |
|
1748
PC Connection
CNXN
$2.12B
| $15.8M | ﹤0.01% |
252,870
+1,149
| +0.5% | +$76.3K |
|
1749
LeMaitre Vascular
LMAT
$1.86B
| $15.7M | ﹤0.01% |
186,589
-9,163
| -5% | -$852K |
|
1750
Delek US
DK
$3.58B
| $15.6M | ﹤0.01% |
1,037,599
+270,792
| +35% | +$4.69M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.